Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ofatumumab Added to Dexamethasone in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia

NCT01310101 is registered in ClinicalTrials.gov with Brno University Hospital as lead sponsor.

NCT NCT01310101
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01310101 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ofatumumab Added to Dexamethasone in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia
Lead sponsor
Brno University Hospital
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2011
Completion date
February 28, 2015
Enrollment
33 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

chronic lymphocytic leukemia